INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF

The invention provides an inactivated varicella zoster virus (VZV), and compositions and vaccines comprising said inactivated VZV, wherein the infectivity of the VZV is undetectable and wherein the inactivated VZV induces an immune response against VZV when administered to a patient. In embodiments...

Full description

Saved in:
Bibliographic Details
Main Authors YAGODICH MARY, BARR COLLEEN M, DEHAVEN JILL, KRISS JENNIFER A, KRAH DAVID L
Format Patent
LanguageEnglish
Korean
Published 09.04.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention provides an inactivated varicella zoster virus (VZV), and compositions and vaccines comprising said inactivated VZV, wherein the infectivity of the VZV is undetectable and wherein the inactivated VZV induces an immune response against VZV when administered to a patient. In embodiments of the compositions described herein, the VZV is inactivated with gamma radiation. The invention also provides a method of preparing an inactivated VZV vaccine, the method comprising gamma irradiating a sample comprising a VZV using from about 5 kGy to about 50 kGy of gamma radiation. Also provided by the invention herein is a method of treatment of or immunization against HZ or other disease associated with the reactivation of VZV, the method comprising administering to a subject a vaccine or pharmaceutical composition comprising a therapeutically effective amount of an inactivated VZV and a pharmaceutically acceptable carrier, wherein the VZV is inactivated by gamma irradiation.
AbstractList The invention provides an inactivated varicella zoster virus (VZV), and compositions and vaccines comprising said inactivated VZV, wherein the infectivity of the VZV is undetectable and wherein the inactivated VZV induces an immune response against VZV when administered to a patient. In embodiments of the compositions described herein, the VZV is inactivated with gamma radiation. The invention also provides a method of preparing an inactivated VZV vaccine, the method comprising gamma irradiating a sample comprising a VZV using from about 5 kGy to about 50 kGy of gamma radiation. Also provided by the invention herein is a method of treatment of or immunization against HZ or other disease associated with the reactivation of VZV, the method comprising administering to a subject a vaccine or pharmaceutical composition comprising a therapeutically effective amount of an inactivated VZV and a pharmaceutically acceptable carrier, wherein the VZV is inactivated by gamma irradiation.
Author KRISS JENNIFER A
DEHAVEN JILL
KRAH DAVID L
YAGODICH MARY
BARR COLLEEN M
Author_xml – fullname: YAGODICH MARY
– fullname: BARR COLLEEN M
– fullname: DEHAVEN JILL
– fullname: KRISS JENNIFER A
– fullname: KRAH DAVID L
BookMark eNqNi7sKwjAUQDPo4KP_cMG1Qmyge0huSLAmktx2cClF4iRtof4_dvADnA4cztmzzTiNecfIeanIdZJQQyejU9g0Eh4hEUboXGzTqpVyHlMJNyQbdIJg4B6Dbtcz-BKk19AmTEAWIwZzZNvX8F5y8eOBnQySsuc8T31e5uGZx_zpr7HiF8G5qHldSfFf9QU4GTK2
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20130036062A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20130036062A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:54:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20130036062A3
Notes Application Number: KR20137002903
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130409&DB=EPODOC&CC=KR&NR=20130036062A
ParticipantIDs epo_espacenet_KR20130036062A
PublicationCentury 2000
PublicationDate 20130409
PublicationDateYYYYMMDD 2013-04-09
PublicationDate_xml – month: 04
  year: 2013
  text: 20130409
  day: 09
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies MERCK SHARP & DOHME CORP
RelatedCompanies_xml – name: MERCK SHARP & DOHME CORP
Score 2.8603015
Snippet The invention provides an inactivated varicella zoster virus (VZV), and compositions and vaccines comprising said inactivated VZV, wherein the infectivity of...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130409&DB=EPODOC&locale=&CC=KR&NR=20130036062A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1dT8IwFL1BNOqbosYPNE00e2IRxljggZjRdhkCKynbQnwhbMzEaIDIjH_f2wrKE-lL0yZNe5N7Tj9u7wF4aCEpKPETM6vOmqbdyFKzmSQ1s5E6aT2xkdK0HNAgcPzIfh43xgX42PyF0XlCv3VyRPSoFP0913i9_L_EYjq2cvWYvGHT4skL28xYn44RkPG8YrBOmw8FE9SgtN2TRiB_-xCtq47l7sG-2kirTPs87qh_KcttUvFO4GCI483zUyi8L0pwRDfaayU4HKyfvLG69r7VGYTdQMV8xC6iDYld2aW833fJixjhnpTEXRmNsJlSJaRRIQMe-oKNiPDIUAoW6WiRCnEDRiIEURL6XHLhncO9x0Pqmzi9yZ81Jj25vZb6BRTni3l2CWRay2YWkhKWRFGOzsOjGD6zXpuOk15BeddI17u7b-DY0koQtlltlaGYf35lt8jHeXKnzfgDamiE_A
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bT8IwFD5BNOKbosYLahPNnliEMSY8EDPaLZvsQsq2EF-IGzMxGiAy49_3tILyRPrStEnTnuR8Xy-n5wO46yIpCPETNW9MO6rezjO1k6ZNtZ0ZWSvVkdKkHJAfGE6sP43b4xJ8rP_CyDyh3zI5InpUhv5eSLxe_F9iMRlbubxP37Bp_mhHPaasTscIyHheUVi_Zw1DFlKF0t6AKwH_7UO0bhiauQO7DyI_r9g8JX3xL2WxSSr2IewNcbxZcQSl93kVKnStvVaFfX_15I3VlfctjyFyAxHzkZiINiQxuUstzzPJczjCPSlJXB6PsJlSIaRRJ74VOSEbkdAmQx6yWEaL1IkZMBIjiJLIsbgV2idwa1sRdVSc3uTPGpMB31xL6xTKs_ksPwPy0synGpISllRQjszDIxg-1147hpGdQ23bSBfbu2-g4kS-N_HcYHAJB5pUhdDVRrcG5eLzK79Cbi7Sa2nSH8tYh-k
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INACTIVATED+VARICELLA+ZOSTER+VIRUS+VACCINES%2C+METHODS+OF+PRODUCTION%2C+AND+USES+THEREOF&rft.inventor=YAGODICH+MARY&rft.inventor=BARR+COLLEEN+M&rft.inventor=DEHAVEN+JILL&rft.inventor=KRISS+JENNIFER+A&rft.inventor=KRAH+DAVID+L&rft.date=2013-04-09&rft.externalDBID=A&rft.externalDocID=KR20130036062A